Compare
02/22/2025 2025-02-22 23:41Compare
| V-Line Sol remove | Replengen Fine remove | Yuvenis remove | |||
|---|---|---|---|---|---|
| Name | V-Line Sol remove | Replengen Fine remove | Yuvenis remove | ||
| Image | ![]() | ![]() | ![]() | ||
| SKU | FM-02-15553 | FM-02-15547 | FM-02-15585 | ||
| Rating | |||||
| Price | $77.00 | $37.00 | $189.00 | ||
| Stock | |||||
| Availability | |||||
| Add to cart | |||||
| Description | |||||
| Content | V-Line Sol – Lipolytics Injectable V-Line Sol is a lipolytic solution tailored for reducing stubborn fat deposits in targeted areas. It promotes contour refinement, helping achieve a slimmer and more defined silhouette. Key Benefits
Professional Use OnlyV-Line Sol must be administered exclusively by licensed medical professionals or certified aesthetic practitioners. Dosage and injection sites should be customized to each patient’s needs. Additional InformationCountry of Origin: Korea | Replengen Fine – Dermal Fillers Injectable Replengen Fine is a specialized dermal filler formulated for delicate corrections and superficial wrinkle treatment. Its smooth consistency allows for precise application, ensuring natural-looking results in sensitive areas. Key Benefits
Professional Use OnlyReplengen Fine must be administered exclusively by licensed medical professionals or certified aesthetic practitioners. Dosage and injection sites should be customized to each patient’s needs. Additional InformationCountry of Origin: Korea | Yuvenis – PDRN Injectable Yuvenis is an advanced pdrn created for versatile facial rejuvenation. It restores lost volume, smooths wrinkles, and enhances contours, delivering youthful results with excellent safety and biocompatibility. Key Benefits
Professional Use OnlyYuvenis must be administered exclusively by licensed medical professionals or certified aesthetic practitioners. Dosage and injection sites should be customized to each patient’s needs. Additional InformationCountry of Origin: Korea | ||
| Weight | N/A | N/A | N/A | ||
| Dimensions | N/A | N/A | N/A | ||
| Additional information |
|


